{"count": 14, "results": [{"_id": "19640331", "pmid": 19640331, "title": "Effect of simvastatin on plasma interleukin-6 in patients with unstable angina.", "journal": "Clin Invest Med", "authors": ["Ren HZ", "Ma LL", "Wang LX"], "date": "2009-08-01T00:00:00Z", "doi": "10.25011/cim.v32i4.6619", "meta_date_publication": "2009 Aug 1", "meta_volume": "32", "meta_issue": "4", "meta_pages": "E280-4", "score": 50076.47, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on plasma @GENE_IL6 @GENE_3569 @@@interleukin-6@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@unstable angina@@@.", "citations": {"NLM": "Ren HZ, Ma LL, Wang LX. Effect of simvastatin on plasma interleukin-6 in patients with unstable angina. Clin Invest Med. 2009 Aug 1;32(4):E280-4. PMID: 19640331", "BibTeX": "@article{19640331, title={Effect of simvastatin on plasma interleukin-6 in patients with unstable angina.}, author={Ren HZ and Ma LL and Wang LX}, journal={Clin Invest Med}, volume={32}, number={4}, pages={E280-4}}"}}, {"_id": "16999946", "pmid": 16999946, "title": "Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina.", "journal": "Clin Chim Acta", "authors": ["Li JJ", "Wang Y", "Nie SP", "Zhang CY", "Li YS", "Hui RT", "Zhen X"], "date": "2007-02-01T00:00:00Z", "doi": "10.1016/j.cca.2006.08.012", "meta_date_publication": "2007 Feb", "meta_volume": "376", "meta_issue": "1-2", "meta_pages": "163-7", "score": 50072.58, "text_hl": "Reduction of @GENE_CRP @GENE_1401 @@@C-reactive protein@@@ by a single 80 mg of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@unstable angina@@@.", "citations": {"NLM": "Li JJ, Wang Y, Nie SP, Zhang CY, Li YS, Hui RT, Zhen X. Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina. Clin Chim Acta. 2007 Feb;376(1-2):163-7. PMID: 16999946", "BibTeX": "@article{16999946, title={Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina.}, author={Li JJ and Wang Y and Nie SP and Zhang CY and Li YS and Hui RT and Zhen X}, journal={Clin Chim Acta}, volume={376}, number={1-2}, pages={163-7}}"}}, {"_id": "15799170", "pmid": 15799170, "title": "Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin.", "journal": "Heart Vessels", "authors": ["Luo Y", "Jiang D", "Wen D", "Yang J", "Li L"], "date": "2004-11-01T00:00:00Z", "doi": "10.1007/s00380-004-0776-6", "meta_date_publication": "2004 Nov", "meta_volume": "19", "meta_issue": "6", "meta_pages": "257-62", "score": 50061.055, "text_hl": "@SPECIES_9606 @@@Patients@@@ in the @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@ACS@@@ group were randomly assigned to a @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group (including a @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@AMI@@@ subgroup, n = 11 and a @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@UA@@@ subgroup, n = 14) and a routine group (including a routine @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@AMI@@@ subgroup, n = 9 and a routine @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@UA@@@ subgroup, n = 16). ", "citations": {"NLM": "Luo Y, Jiang D, Wen D, Yang J, Li L. Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin. Heart Vessels. 2004 Nov;19(6):257-62. PMID: 15799170", "BibTeX": "@article{15799170, title={Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin.}, author={Luo Y and Jiang D and Wen D and Yang J and Li L}, journal={Heart Vessels}, volume={19}, number={6}, pages={257-62}}"}}, {"_id": "25066560", "pmid": 25066560, "title": "Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.", "journal": "Am Heart J", "authors": ["Blazing MA", "Giugliano RP", "Cannon CP", "Musliner TA", "Tershakovec AM", "White JA", "Reist C", "McCagg A", "Braunwald E", "Califf RM"], "date": "2014-08-01T00:00:00Z", "doi": "10.1016/j.ahj.2014.05.004", "meta_date_publication": "2014 Aug", "meta_volume": "168", "meta_issue": "2", "meta_pages": "205-12.e1", "score": 50059.55, "text_hl": "The @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ monotherapy arm's LDL-C target is <70 mg/dL. ", "citations": {"NLM": "Blazing MA, Giugliano RP, Cannon CP, Musliner TA, Tershakovec AM, White JA, Reist C, McCagg A, Braunwald E, Califf RM. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. Am Heart J. 2014 Aug;168(2):205-12.e1. PMID: 25066560", "BibTeX": "@article{25066560, title={Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.}, author={Blazing MA and Giugliano RP and Cannon CP and Musliner TA and Tershakovec AM and White JA and Reist C and McCagg A and Braunwald E and Califf RM}, journal={Am Heart J}, volume={168}, number={2}, pages={205-12.e1}}"}}, {"_id": "25692840", "pmid": 25692840, "title": "[IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (studie IMPROVE-IT)].", "journal": "Vnitr Lek", "authors": ["Špinar J", "Špinarová L", "Vítovec J"], "date": "2014-12-01T00:00:00Z", "meta_date_publication": "2014 Dec", "meta_volume": "60", "meta_issue": "12", "meta_pages": "1095-101", "score": 50058.184, "text_hl": "Compared to @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@ given the drug @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ plus a placebo, those given both @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and the non-statin drug, @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@, had a 6.4 % lower combined risk of subsequent @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@heart attack@@@, @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@, @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular death@@@, rehospitalization for @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@unstable angina@@@ and procedures to restore blood flow to the heart. ", "citations": {"NLM": "Špinar J, Špinarová L, Vítovec J. [IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (studie IMPROVE-IT)]. Vnitr Lek. 2014 Dec;60(12):1095-101. PMID: 25692840", "BibTeX": "@article{25692840, title={[IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (studie IMPROVE-IT)].}, author={Špinar J and Špinarová L and Vítovec J}, journal={Vnitr Lek}, volume={60}, number={12}, pages={1095-101}}"}}, {"_id": "25177808", "pmid": 25177808, "title": "[Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].", "journal": "Kardiologiia", "authors": ["Agmadova ZM", "Kallaeva AN"], "date": "2014-01-01T00:00:00Z", "doi": "10.18565/cardio.2014.7.9-16", "meta_date_publication": "2014", "meta_volume": "54", "meta_issue": "7", "meta_pages": "9-16", "score": 50057.85, "text_hl": "IMPLICATION: The use of complex therapy with @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@acetylsalicylic acid@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@UA@@@, @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@, @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is justified for prevention @DISEASE_Ventricular_Remodeling @DISEASE_MESH:D020257 @@@LV remodeling@@@ and lowering of rate of acute @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@ recurrence and @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@CHF@@@ development.", "citations": {"NLM": "Agmadova ZM, Kallaeva AN. [Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina]. Kardiologiia. 2014;54(7):9-16. PMID: 25177808", "BibTeX": "@article{25177808, title={[Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].}, author={Agmadova ZM and Kallaeva AN}, journal={Kardiologiia}, volume={54}, number={7}, pages={9-16}}"}}, {"_id": "22088858", "pmid": 22088858, "title": "[Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].", "journal": "Anadolu Kardiyol Derg", "authors": ["Namal E", "Sener N", "Ulaş T", "Akçalı Z", "Oztekin E", "Borlu F"], "date": "2011-12-01T00:00:00Z", "doi": "10.5152/akd.2011.192", "meta_date_publication": "2011 Dec", "meta_volume": "11", "meta_issue": "8", "meta_pages": "703-10", "score": 50056.742, "text_hl": "[Effects of different statins, @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ combination on hsCRP levels in @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@unstable angina pectoris@@@ and non-@DISEASE_ST_Elevation_Myocardial_Infarction @DISEASE_MESH:D000072657 @@@ST@@@ elevation @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ @SPECIES_9606 @@@patients@@@: a randomized trial].", "citations": {"NLM": "Namal E, Sener N, Ulaş T, Akçalı Z, Oztekin E, Borlu F. [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial]. Anadolu Kardiyol Derg. 2011 Dec;11(8):703-10. PMID: 22088858", "BibTeX": "@article{22088858, title={[Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].}, author={Namal E and Sener N and Ulaş T and Akçalı Z and Oztekin E and Borlu F}, journal={Anadolu Kardiyol Derg}, volume={11}, number={8}, pages={703-10}}"}}, {"_id": "12877794", "pmid": 12877794, "title": "Lipid-lowering efficacy and safety of varying doses of Simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study.", "journal": "Chin Med J (Engl)", "authors": ["Zou Y", "Hu D", "Yang X", "Xu Z", "Cui L", "Liu X", "Wei Y", "Gao M"], "date": "2003-06-01T00:00:00Z", "meta_date_publication": "2003 Jun", "meta_volume": "116", "meta_issue": "6", "meta_pages": "853-6", "score": 50049.215, "text_hl": "OBJECTIVE: To investigate whether @SPECIES_9606 @@@patients@@@, who are at risk of major @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@acute coronary events@@@, are safe to undergo and benefit from early intervention after using @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. METHODS: The study was a randomized, open, two-dosage-controlled trial to evaluate the safety and benefits of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ administered to 197 @SPECIES_9606 @@@patients@@@ (10 mg group, n = 98 and 20 mg group, n = 99), within 48 hours of hospitalization for a diagnosis of @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@unstable angina@@@ or acute @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (MI), with total @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ (TC) >/= 180 mg/dL or low-density lipoprotein cholesterol (LDL-C) >/= 100 mg/dL. ", "citations": {"NLM": "Zou Y, Hu D, Yang X, Xu Z, Cui L, Liu X, Wei Y, Gao M. Lipid-lowering efficacy and safety of varying doses of Simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study. Chin Med J (Engl). 2003 Jun;116(6):853-6. PMID: 12877794", "BibTeX": "@article{12877794, title={Lipid-lowering efficacy and safety of varying doses of Simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study.}, author={Zou Y and Hu D and Yang X and Xu Z and Cui L and Liu X and Wei Y and Gao M}, journal={Chin Med J (Engl)}, volume={116}, number={6}, pages={853-6}}"}}, {"_id": "26821621", "pmid": 26821621, "title": "Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.", "journal": "J Am Coll Cardiol", "authors": ["Murphy SA", "Cannon CP", "Blazing MA", "Giugliano RP", "White JA", "Lokhnygina Y", "Reist C", "Im K", "Bohula EA", "Isaza D", "Lopez-Sendon J", "Dellborg M", "Kher U", "Tershakovec AM", "Braunwald E"], "date": "2016-02-02T00:00:00Z", "doi": "10.1016/j.jacc.2015.10.077", "meta_date_publication": "2016 Feb 2", "meta_volume": "67", "meta_issue": "4", "meta_pages": "353-361", "score": 50049.094, "text_hl": "METHODS: All PEP events (@DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular [CV] death@@@, @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ [MI], @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@, @<m>DISEASE_Angina_Unstable</m> @DISEASE_MESH:D000789 @@@unstable angina@@@ [UA] leading to hospitalization, coronary revascularization >=30 days post-randomization) during a median 6-year follow-up were analyzed in @SPECIES_9606 @@@patients@@@ randomized to receive @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or placebo/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in IMPROVE-IT. ", "citations": {"NLM": "Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, Reist C, Im K, Bohula EA, Isaza D, Lopez-Sendon J, Dellborg M, Kher U, Tershakovec AM, Braunwald E. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. J Am Coll Cardiol. 2016 Feb 2;67(4):353-361. PMID: 26821621", "BibTeX": "@article{26821621, title={Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.}, author={Murphy SA and Cannon CP and Blazing MA and Giugliano RP and White JA and Lokhnygina Y and Reist C and Im K and Bohula EA and Isaza D and Lopez-Sendon J and Dellborg M and Kher U and Tershakovec AM and Braunwald E}, journal={J Am Coll Cardiol}, volume={67}, number={4}, pages={353-361}}"}}, {"_id": "10972631", "pmid": 10972631, "title": "Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study.", "journal": "Clin Ther", "authors": ["Pedersen TR", "Jahnsen KE", "Vatn S", "Semb AG", "Kontny F", "Zalmai A", "Nerdrum T"], "date": "2000-08-01T00:00:00Z", "doi": "10.1016/S0149-2918(00)80066-1", "meta_date_publication": "2000 Aug", "meta_volume": "22", "meta_issue": "8", "meta_pages": "949-60", "score": 50047.31, "text_hl": "RESULTS: The immediate-@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group (n = 73) and the deferred-@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group (n = 78) were balanced with respect to baseline characteristics. ", "citations": {"NLM": "Pedersen TR, Jahnsen KE, Vatn S, Semb AG, Kontny F, Zalmai A, Nerdrum T. Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study. Clin Ther. 2000 Aug;22(8):949-60. PMID: 10972631", "BibTeX": "@article{10972631, title={Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study.}, author={Pedersen TR and Jahnsen KE and Vatn S and Semb AG and Kontny F and Zalmai A and Nerdrum T}, journal={Clin Ther}, volume={22}, number={8}, pages={949-60}}"}}]}